Dr. Avramis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Coit Rd
Ste 104
Plano, TX 75075Phone+1 972-985-2797Fax+1 972-985-4797
Summary
- Dr. Ioannis Avramis is an orthopedic surgeon in Dallas, TX and is affiliated with multiple hospitals in the area, including Baylor University Medical Center andBaylor Scott & White Medical Center Plano. He received his medical degree from University of California Davis School of Medicine and has been in practice 11 years. He specializes in orthopedic spine surgery and is experienced in scoliosis and revision spine surgery, spinal deformity surgery, and general spine surgery.
Education & Training
- University of California Davis HealthFellowship, Orthopaedic Surgery Of The Spine, 2011 - 2012
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Orthopaedic Surgery, 2006 - 2011
- University of California, Davis, School of MedicineClass of 2006
Certifications & Licensure
- TX State Medical License 2012 - 2025
- CA State Medical License 2008 - 2024
- American Board of Orthopaedic Surgery Orthopaedic Surgery
Publications & Presentations
PubMed
- 191 citationsAsparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.Eduard H. Panosyan, Nita L. Seibel, Sagrario Martin-Aragon, Paul S. Gaynon, Ioannis A. Avramis
Journal of Pediatric Hematology/oncology. 2004-04-01 - 37 citationsChanges of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961).Rita S. Grigoryan, Eduard H. Panosyan, Nita L. Seibel, Paul S. Gaynon, Ioannis A. Avramis
In Vivo. 2004-03-01 - 34 citationsDetermination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against ...Ioannis A. Avramis, Walter E. Laug, Edward A. Sausville, Vassilios I. Avramis
Cancer Chemotherapy and Pharmacology. 2003-06-25
Press Mentions
- Considering Spine Surgery? Here Are 7 of Dallas’ Renowned ProvidersDecember 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: